The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Self-citationCancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Self-citationKaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni1009 · Cited by 1,830 · cited 1×
“The homeostatic expansion of memory CD8+ T cells does not rely solely on IL-7, however, these cells do constitutively express high levels of both IL-7Rα (CD127) and the components of the IL-15–IL-2 heterodimeric complex, IL-2– IL-15Rβ(CD122) and γc (CD132), and thus might be sensitive to IL-7 [30,38,42].”
BackgroundInterleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575
Self-citationShimizu, J., Yamazaki, S., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5211 · Cited by 1,491
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., et al. (1994) · Science · doi:10.1126/science.8178155 · Cited by 1,422
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Kaech, S. M., & Ahmed, R. (2001) · Nature Immunology · doi:10.1038/87720 · Cited by 1,278
Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15
Zhang, X., Sun, S., Hwang, I., Tough, D. F., & Sprent, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80564-6 · Cited by 1,245
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,108
Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo
Tough, D. F., Borrow, P., & Sprent, J. (1996) · Science · doi:10.1126/science.272.5270.1947 · Cited by 1,077
A Critical Role for IL-21 in Regulating Immunoglobulin Production
Ozaki, K., Spolski, R., Feng, C. G., Qi, C.-F., Cheng, J., Sher, A., Morse, H. C., Liu, C., Schwartzberg, P. L., & Leonard, W. J. (2002) · Science · doi:10.1126/science.1077002 · Cited by 978
IL-7 is critical for homeostatic proliferation and survival of naïve T cells
Tan, J. T., Dudl, E., LeRoy, E., Murray, R., Sprent, J., Weinberg, K. I., & Surh, C. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161126098 · Cited by 965
Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Mottet, C., Uhlig, H. H., & Powrie, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3939 · Cited by 927
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Self-citationSuri-Payer, E., Amar, A. Z., Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1212 · Cited by 860
van Stipdonk, M. J. B., Lemmens, E. E., & Schoenberger, S. P. (2001) · Nature Immunology · doi:10.1038/87730 · Cited by 841
Hill, G. R., Crawford, J. M., Cooke, K. R., Brinson, Y. S., Pan, L., & Ferrara, J. L. M. (1997) · Blood · doi:10.1182/blood.v90.8.3204 · Cited by 832
Tan, J. T., Ernst, B., Kieper, W. C., LeRoy, E., Sprent, J., & Surh, C. D. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020066 · Cited by 786
CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rβ-Deficient Mice
Malek, T. R., Yu, A., Vincek, V., Scibelli, P., & Kong, L. (2002) · Immunity · doi:10.1016/s1074-7613(02)00367-9 · Cited by 779
Ernst, B., Lee, D.-S., Chang, J. M., Sprent, J., & Surh, C. D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80092-8 · Cited by 717
Selecting and maintaining a diverse T-cell repertoire
Goldrath, A. W., & Bevan, M. J. (1999) · Nature · doi:10.1038/35005508 · Cited by 714
Dudley, M. E., Wunderlich, J. R., Shelton, T. E., Even, J., & Rosenberg, S. A. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200307000-00005 · Cited by 701
Woo, E. Y., Yeh, H., Chu, C. S., Schlienger, K., Carroll, R. G., Riley, J. L., Kaiser, L. R., & June, C. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4272 · Cited by 696
Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells
Becker, T. C., Wherry, E. J., Boone, D., Murali-Krishna, K., Antia, R., Ma, A., & Ahmed, R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020369 · Cited by 683
Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity
King, C., Ilic, A., Koelsch, K., & Sarvetnick, N. (2004) · Cell · doi:10.1016/s0092-8674(04)00335-6 · Cited by 670
Adoptive-cell-transfer therapy for the treatment of patients with cancer
Dudley, M. E., & Rosenberg, S. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1167 · Cited by 660
Peripheral Selection of the T Cell Repertoire
Rocha, B., & von Boehmer, H. (1991) · Science · doi:10.1126/science.1900951 · Cited by 647
Naive T Cells Transiently Acquire a Memory-like Phenotype during Homeostasis-Driven Proliferation
Goldrath, A. W., Bogatzki, L. Y., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.557 · Cited by 633
Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function
Furtado, G. C., de Lafaille, M. A. C., Kutchukhidze, N., & Lafaille, J. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020190 · Cited by 625
Cytokine Requirements for Acute and Basal Homeostatic Proliferation of Naive and Memory CD8+ T Cells
Goldrath, A. W., Sivakumar, P. V., Glaccum, M., Kennedy, M. K., Bevan, M. J., Benoist, C., Mathis, D., & Butz, E. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020033 · Cited by 587
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8 + T Cells
Klebanoff, C. A., Finkelstein, S. E., Surman, D. R., Lichtman, M. K., Gattinoni, L., Theoret, M. R., Grewal, N., Spiess, P. J., Antony, P. A., Palmer, D. C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307298101 · Cited by 577
Self-citationThornton, A. M., Donovan, E. E., Piccirillo, C. A., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6519 · Cited by 560
Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
Wang, H. Y., Lee, D. A., Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, E. M., & Wang, R.-F. (2004) · Immunity · doi:10.1016/s1074-7613(03)00359-5 · Cited by 515
Cho, B. K., Rao, V. P., Ge, Q., Eisen, H. N., & Chen, J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.549 · Cited by 509
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.277 · Cited by 493
Self-citationCutting Edge: Naive T Cells Masquerading as Memory Cells
Murali-Krishna, K., & Ahmed, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1733 · Cited by 462
Mattei, F., Schiavoni, G., Belardelli, F., & Tough, D. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1179 · Cited by 459
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
Marks-Konczalik, J., Dubois, S., Losi, J. M., Sabzevari, H., Yamada, N., Feigenbaum, L., Waldmann, T. A., & Tagaya, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200363097 · Cited by 433
T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells
Kedl, R. M., Rees, W. A., Hildeman, D. A., Schaefer, B., Mitchell, T., Kappler, J., & Marrack, P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1105 · Cited by 406
Homeostatic proliferation is a barrier to transplantation tolerance
Wu, Z., Bensinger, S. J., Zhang, J., Chen, C., Yuan, X., Huang, X., Markmann, J. F., Kassaee, A., Rosengard, B. R., Hancock, W. W., et al. (2004) · Nature Medicine · doi:10.1038/nm965 · Cited by 401
Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?
Parmiani, G., Castelli, C., Dalerba, P., Mortarini, R., Rivoltini, L., Marincola, F. M., & Anichini, A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.805 · Cited by 401
Burton, J. D., Bamford, R. N., Peters, C., Grant, A. J., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E., & Waldmann, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4935 · Cited by 397
Piccirillo, C. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.12.003 · Cited by 392
Overwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C.-C., Carroll, M. W., Moss, B., Rosenberg, S. A., & Restifo, N. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2982 · Cited by 381
Self-citationXun, C., Thompson, J., Jennings, C., Brown, S., & Widmer, M. (1994) · Blood · doi:10.1182/blood.v83.8.2360.2360 · Cited by 360
Dudley, M. E., Wunderlich, J. R., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R. M., Marincola, F. M., Leitman, S. F., Seipp, C. A., et al. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200205000-00007 · Cited by 357
T Cell Stimulation In Vivo by Lipopolysaccharide (LPS)
Tough, D. F., Sun, S., & Sprent, J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2089 · Cited by 343
Vitiligo in Patients with Melanoma: Normal Tissue Antigens Can Be Targets for Cancer Immunotherapy
Rosenberg, S. A., & White, D. E. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199601000-00009 · Cited by 333
Interleukin 15 Controls both Proliferation and Survival of a Subset of Memory-Phenotype CD8+ T Cells
Judge, A. D., Zhang, X., Fujii, H., Surh, C. D., & Sprent, J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020772 · Cited by 331
T cell homeostatic proliferation elicits effective antitumor autoimmunity
Dummer, W., Niethammer, A. G., Baccalà, R., Lawson, B. R., Wagner, N., Reisfeld, R. A., & Theofilopoulos, A. N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15175 · Cited by 308
Interleukin-7: master regulator of peripheral T-cell homeostasis?
Fry, T. J., & Mackall, C. L. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02028-2 · Cited by 287
Kieper, W. C., Tan, J. T., Bondi-Boyd, B., Gapin, L., Sprent, J., Ceredig, R., & Surh, C. D. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020067 · Cited by 285
Control of Autoimmunity by Naturally Arising Regulatory CD4+ T Cells
(2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81008-8 · Cited by 283
Moroz, A., Eppolito, C., Li, Q., Tao, J., Clegg, C. H., & Shrikant, P. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.900 · Cited by 268
Cheever, M. A., Greenberg, P. D., Fefer, A., & Gillis, S. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.4.968 · Cited by 265
Coupling and Uncoupling of Tumor Immunity and Autoimmunity
Bowne, W. B., Srinivasan, R., Wolchok, J. D., Hawkins, W. G., Blachere, N. E., Dyall, R., Lewis, J. J., & Houghton, A. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1717 · Cited by 239
Fry, T. J. (2003) · Blood · doi:10.1182/blood-2002-07-2297 · Cited by 231
Morrissey, P. J., Goodwin, R. G., Nordan, R. P., Anderson, D., Grabstein, K. H., Cosman, D., Sims, J., Lupton, S., Acres, B., & Reed, S. G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.707 · Cited by 222
In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
Wang, G., Tschoi, M., Spolski, R. J., Lou, Y., Ozaki, K., Feng, C., Kim, G., Leonard, W. J., & Hwu, P. (2003) · PubMed · Cited by 221
Casares, N., Arribillaga, L., Sarobe, P., Dotor, J., Lopez-Diaz de Cerio, A., Melero, I., Prieto, J., Borrás-Cuesta, F., & Lasarte, J. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5931 · Cited by 196
Zhang, Y., Louboutin, J.-P., Zhu, J., Rivera, A. J., & Emerson, S. G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14989 · Cited by 188
Bell, E. B., Sparshott, S. M., Drayson, M. T., & Ford, W. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1379 · Cited by 169
Autologous Regulation of Naive T Cell Homeostasis Within the T Cell Compartment
Dummer, W., Ernst, B., LeRoy, E., Lee, D., & Surh, C. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2460 · Cited by 150
Sherman, M. L., Datta, R., Hallahan, D. E., Weichselbaum, R. R., & Kufe, D. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115199 · Cited by 144
Geiselhart, L., Humphries, C. A., Gregorio, T. A., Mou, S. M., Subleski, J. J., & Komschlies, K. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3019 · Cited by 143
Oehen, S., & Brduscha‐Riem, K. (1999) · European Journal of Immunology · Cited by 140
CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens.
Javia, L. R., & Rosenberg, S. A. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200301000-00009 · Cited by 135
Zheng, L., Trageser, C., Willerford, D. M., & Lenardo, M. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.763 · Cited by 134
Palmer, D. C., Balasubramaniam, S., Hanada, K., Wrzesinski, C., Yu, Z., Farid, S. S., Theoret, M. R., Hwang, L. N., Klebanoff, C. A., Gattinoni, L., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7209 · Cited by 114
Self-citationCancer vaccines: progress reveals new complexities
Yu, Z., & Restifo, N. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16216 · Cited by 97
Self-citationAutoimmunity and the Immunotherapy of Cancer: Targeting the "Self" to Destroy the "Other"
Overwijk, W. W., & Restifo, N. P. (2000) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v20.i6.10 · Cited by 75
Self-citationChernysheva, A., Kirou, K. A., & Crow, M. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1241 · Cited by 48
鳥畑, 秀., Ishikawa, F., Okada, Y., Tanaka, Y., Uchida, T., Suguro, T., & Kakiuchi, T. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01872.x · Cited by 26
Cited by
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Antony, P. A., Piccirillo, C. A., Akpinarli, A., Finkelstein, S. E., Speiss, P. J., Surman, D. R., Palmer, D. C., Chan, C.-C., Klebanoff, C. A., Overwijk, W. W., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2591 · Cited by 760
Self-citationClinical lessons learned from the first leg of the CAR T cell journey
Majzner, R. G., & Mackall, C. L. (2019) · Nature Medicine · doi:10.1038/s41591-019-0564-6 · Cited by 636
Paulos, C. M., Wrzesinski, C., Kaiser, Hinrichs, C. S., Chieppa, M., Cassard, L., Palmer, D. C., Boni, A., Muranski, P., Yu, Z., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32205 · Cited by 586
Self-citationHou, D.-Y., Muller, A. J., Sharma, M. D., DuHadaway, J., Banerjee, T., Johnson, M., Mellor, A. L., Prendergast, G. C., & Munn, D. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2925 · Cited by 586
Metadata
- Authors
- Klebanoff, C. A., Khong, H. T., Antony, P. A., Palmer, D. C., & Restifo, N. P.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 26
- Issue
- 2
- Pages
- 111-117
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W2000297273
- Cited by
- 469
- References
- 81
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.